Fiera Capital Corp Bristol Myers Squibb CO Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

A detailed history of Fiera Capital Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fiera Capital Corp holds 9,511 shares of BMY stock, worth $545,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,511

Previous 8,550 11.24%

Holding current value

$545,265

Previous $355,000 38.59%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$39.66 - $51.75 $38,113 - $49,731	961 Added 11.24%	9,511 $492,000
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $28,175 - $37,093	-700 Reduced 7.57%	8,550 $355,000
Q1 2024 Aug 22, 2024	BUY	$47.98 - $54.4 $33,586 - $38,080	700 Added 8.19%	9,250 $501,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $31,186 - $35,360	-650 Reduced 6.57%	9,250 $501,000
Q4 2023 Aug 22, 2024	BUY	$48.48 - $57.85 $65,447 - $78,097	1,350 Added 15.79%	9,900 $507,000
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $479,951 - $572,715	9,900 New	9,900 $507,000
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $216,908 - $246,023	3,301 Added 21.45%	18,691 $1.3 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $1.76 Million - $2.08 Million	-25,665 Reduced 62.51%	15,390 $1.11 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $97 - $57,553	-749 Reduced 1.79%	41,055 $2.91 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $437,971 - $482,359	6,031 Added 16.86%	41,804 $3.22 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $441,856 - $529,825	-7,187 Reduced 16.73%	35,773 $2.61 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $118,146 - $137,731	-2,203 Reduced 4.88%	42,960 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $814,711 - $954,329	13,769 Added 43.86%	45,163 $2.67 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $1.52 Million - $1.65 Million	24,533 Added 357.57%	31,394 $1.85 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $210,241 - $236,459	3,543 Added 106.78%	6,861 $433,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $19,985 - $22,146	-348 Reduced 9.49%	3,318 $200,000
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $130,033 - $152,021	-2,372 Reduced 39.28%	3,666 $216,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $185,878 - $270,124	-4,006 Reduced 39.88%	6,038 $337,000
Q4 2019 Feb 06, 2020	SELL	$49.21 - $64.19 $208,650 - $272,165	-4,240 Reduced 29.68%	10,044 $644,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $134,340 - $159,280	3,141 Added 28.19%	14,284 $724,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $200,343 - $221,536	4,490 Added 67.49%	11,143 $505,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $48,278 - $57,566	-1,070 Reduced 13.85%	6,653 $318,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $16,090 - $20,865	-330 Reduced 4.1%	7,723 $402,000
Q2 2018 Aug 02, 2018	BUY	$50.53 - $62.98 $188,881 - $235,419	3,738 Added 86.63%	8,053 $446,000
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $27,683 - $31,868	462 Added 11.99%	4,315 $272,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $212,801 - $245,590	3,853	3,853 $245,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Bristol Myers Squibb CO Transaction History